Dihydropteridine reductase in schizophrenic patients. 1985

H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor

The activity of the enzyme dihydropteridine reductase (DHPR) has been recently found to be one of the factors controlling the rate of synthesis of dopamine, norepinephrine, and serotonin, thought to be involved in the etiology of schizophrenia. Several lines of evidence suggest that peripheral and brain DHPR enzymes may be identical. In addition, peripheral DHPR activity has been hypothesized to be important in determining the level of phenylethylamine, a putative psychotogen that is produced peripherally and crosses the blood-brain barrier. Since DHPR activity has never been investigated in schizophrenic patients, we measured the whole blood activity in 20 schizophrenic patients and 20 matched controls. There was no difference between the groups in DHPR activity.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009247 NADH, NADPH Oxidoreductases A group of oxidoreductases that act on NADH or NADPH. In general, enzymes using NADH or NADPH to reduce a substrate are classified according to the reverse reaction, in which NAD+ or NADP+ is formally regarded as an acceptor. This subclass includes only those enzymes in which some other redox carrier is the acceptor. (Enzyme Nomenclature, 1992, p100) EC 1.6. Oxidoreductases, NADH, NADPH,NADPH Oxidoreductases NADH,Oxidoreductases NADH, NADPH
D004093 Dihydropteridine Reductase An enzyme that catalyzes the reduction of 6,7-dihydropteridine to 5,6,7,8-tetrahydropteridine in the presence of NADP+. Defects in the enzyme are a cause of PHENYLKETONURIA II. Formerly listed as EC 1.6.99.7. 6,7-Dihydropteridine Reductase,6,7 Dihydropteridine Reductase,Reductase, 6,7-Dihydropteridine,Reductase, Dihydropteridine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012559 Schizophrenia A severe emotional disorder of psychotic depth characteristically marked by a retreat from reality with delusion formation, HALLUCINATIONS, emotional disharmony, and regressive behavior. Dementia Praecox,Schizophrenic Disorders,Disorder, Schizophrenic,Disorders, Schizophrenic,Schizophrenias,Schizophrenic Disorder

Related Publications

H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
December 1987, The New England journal of medicine,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
February 1986, The New England journal of medicine,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
March 1987, Nucleic acids research,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
August 2016, Journal of the neurological sciences,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
January 1990, The Turkish journal of pediatrics,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
April 2012, Molecular genetics and metabolism,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
January 1987, Methods in enzymology,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
October 1980, Biochemical Society transactions,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
October 1988, The Biochemical journal,
H V Szymanski, and A Orfanos, and K Narisawa, and R Grosz, and E W Naylor
January 1987, Methods in enzymology,
Copied contents to your clipboard!